University of Cambridge - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

University of Cambridge - Pharmaceuticals & Healthcare - Deals and Alliances Profile

University of Cambridge - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
University of Cambridge - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 27, 2016
50 pages — Published Sep 27, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

University of Cambridge (UC) is an educational and research institute that offers undergraduate and graduate studies. The institute offers undergraduate courses in areas of architecture, chemical engineering, classics, computer science, economics, education, engineering, English, land economy, law, linguistics, natural sciences, human, social, and political sciences, veterinary medicine, theology and religious studies, philosophy, psychological and behavioral sciences, mathematics, medicine and management studies. It provides undergraduate program through its affiliated colleges.

University of Cambridge - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, de

  
Source:
Document ID
GDPH72454D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables41
  List of Figures51
University of Cambridge, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201652
University of Cambridge, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201671
University of Cambridge, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201681
University of Cambridge, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201691
University of Cambridge, Medical Devices Deals, 2010 to YTD 2016101
University of Cambridge, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016113
University of Cambridge, Pharmaceuticals &Healthcare, Deal Details1432
  Venture Financing141
    DefiniGEN Raises USD2.2 Million in Venture Financing142
    Cambridge Epigenetix Raises USD21 Million in Series B Financing161
    Quethera Raises Funds in Seed Financing Round171
    PhoreMost Raises USD3.8 Million in Seed Financing181
    Fluidic Analytics Raises USD2.4 Million in Series A Venture Financing192
    Cambridge Epigenetix Raises USD5.5 Million in Series A Venture Financing211
    DefiniGEN Raises USD3.8 Million in Series A Financing222
    Sphere Fluidics Raises US$2.5 Million In Venture Financing242
    Sphere Fluidics Raises Funds through Seed Financing261
  Partnerships271
    Genestack Partners with Cancer Molecular Diagnostic Laboratory271
    OncoTherics Enters into Agreement with University of Cambridge281
    AstraZeneca and MedImmune Enter into R&D Agreement with University of Cambridge292
    MedImmune Enters Into Research Agreement With Cambridge University311
    GlaxoSmithKline Enters Into Co-Development Agreement With University of Cambridge321
    University of Cambridge Enters Into Joint Venture Agreement With Elan331
    Phylogica Enters Into Joint Venture Agreement With University Of Cambridge341
    AstraZeneca Enters Into Joint Venture With Sanofi, University Of Cambridge, EPFL, And Universities Of Pavia And Uppsala352
  Licensing Agreements371
    Cantabio Pharma Enters into Licensing Agreement with University of Cambridge371
    DefiniGEN Enters into Licensing Agreement with University of Cambridge381
    Sphere Fluidics Enters Into Licensing Agreement with Cambridge University for Picodroplets391
    Sphere Fluidics Enters Into Licensing Agreement with Cambridge University401
  Acquisition411
    Nihon Trim To Acquire 50.1% Stake In StemCell Institute For US$5.3 Million411
    SuperGen Completes Acquisition Of Astex Therapeutics424
University of Cambridge - Key Competitors461
Key Employees471
Locations And Subsidiaries482
  Head Office481
  Other Locations &Subsidiaries482
Appendix501
  Methodology501
  About GlobalData501
  Contact Us501
  Disclaimer501

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "University of Cambridge - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 27, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Cambridge-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7807>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). University of Cambridge - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 27, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/University-of-Cambridge-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7807>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research